IFS Applications selected by one of the largest Latin

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 1, 2013 at 11:15 AM

IFS Applications selected by one of the largest Latin American pharmaceutical companies

IFS, the global enterprise applications company, has been selected to provide enterprise resource planning (ERP) software to The Butantan Institute, a Brazilian biomedical research center affiliated to the São Paulo State Secretary of Health. The agreement includes licenses and services valued in excess of USD 2 million. The Butantan Institute is one of the largest biomedical research centers in the world, and produces 90 percent of the vaccines and serums used in Brazil for preventive and curative use. The Butantan Institute also conducts public health -related studies and research, and conducts scientific missions in Brazil and abroad through major non-governmental organizations like the World Health Organization, UNICEF and the United Nations. “IFS is a proven and safe choice in major enterprise software selection processes in Latin America,” LatinIFS CEO Lávio Falcão said. “We have built-in support for Brazilian tax code including Nota Fiscal Documents, and a strong service and support presence in the region. Particularly in industries that are heavily regulated, requiring serialization and documented quality processes, we plan to remain a significant force in Latin America.” Process manufacturing is one of IFS’ targeted markets. IFS provide industry -specific functionality for enterprises in chemicals, food & beverage, paint & ink, and pharmaceuticals. IFS Applications™ supports all critical business processes, including material compliance, batch balancing, recipe management, quality management and demand planning. The application suite also includes solutions for enterprise asset management, product lifecycle management, customer relationship management, finance and human resource management. IFS process manufacturing customers include Jotun, Dyrup, Willamette Valley Company, AkzoNobel, Sherwin-Williams, Farrow & Ball, Teknos, Imerys, Becker Industrial Coatings, ACO Hud, LGC Ltd, Neste Oil, Oriflame, Heaven Hill Distilleries Inc, Bridor, Cloetta, Boyd’s Coffe, Tazo Tea, W.Grants, Bolix S.a., Diamond Pet Foods, Kettle Foods, Bronco Wine and Chingford Fruit. About the Butantan Institute After an 1899 outbreak of bubonic plague in the port of Santos in 1899, the government to acquire the Butantan Farm and installed a laboratory for the production of anti-plague serum. This laboratory was recognized as an autonomous institution in February 1901. Today, The Institute conducts biomedical research in many areas, including molecular biology, immunology and epidemiology. Besides its research laboratories, production units and specialized library, it operates an animal breeding center used to generate antidotes for various bites and stings, and accepts donations of serpents, arthropods and other animals. The Butantan Institute is one of the major tourist and educational attractions in a vast park area in the of Butantã neighborhood in São Paulo. It has a serpentarium, a historical museum, a biological museum, and a museum of microbiology. The venom farm is a major attraction, and visitors can see the snakes housed in representations of their natural environments. The park also contains a number of rare species of tree. More information on The Butantan Institute is available at www.butantan.gov.br. About IFS IFS™ is a public company (XSTO: IFS) founded in 1983 that develops, supplies, and implements IFS Applications™, a component-based extended ERP suite. IFS focuses on industries where management of any of the following four core processes is strategic: service & asset, manufacturing, supply chain, and projects. The company has 2,100 customers and is present in approximately 60 countries with 2,800 employees in total. Net revenue in 2012 was SKr 2.7 billion. More information on IFS is available at www.IFSWORLD.com Follow us on Twitter: @ifsworld Visit the IFS Blogs on technology, innovation and creativity: http://blogs.ifsworld.com/ IFS discloses the information herein pursuant to the Financial Instruments Act (1991:980) and/or the Securities Markets Act (2007:528). The information was submitted for publication on August 1, 2013, at 5:00 p.m. CEST. Contact Information Mark Boulton Telefon: 44 1494 428900 Chief Marketing Officer press@ifsworld.com (mark.boulton@ifsworld.com) Frédéric Guigues Telefon: 46 8 58 78 45 00 Investor Relations frederic.guigues@ifsworld.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...